The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials
Autor: | Galvano, A., Gristina, V., Malapelle, U., Pisapia, P., Pepe, F., Barraco, N., Castiglia, M., Perez, A., Rolfo, C., Troncone, G., Russo, A., Bazan, V. |
---|---|
Zdroj: | In ESMO Open June 2021 6(3) |
Databáze: | ScienceDirect |
Externí odkaz: |